Which formulation and concentration of capsaicin is appropriate for treating herpes zoster?

High-Concentration Capsaicin 8% Patch for Postherpetic Neuralgia

For treating postherpetic neuralgia (the neuropathic pain complication of herpes zoster), use the high-concentration capsaicin 8% patch applied for 60 minutes to the painful area, which can be repeated every 90 days if pain persists. 1

Formulation and Concentration

The evidence strongly supports high-concentration capsaicin 8% patch over low-concentration formulations:

• Low-concentration capsaicin (0.025-0.075% creams) is considered only third-line treatment with limited efficacy 1
• High-concentration 8% patch delivers approximately 100 times more capsaicin than conventional creams and has robust Phase 3 trial evidence 2, 3
• The FDA-labeled low-concentration capsaicin 0.035% cream 4 requires 3-4 times daily application 4 and lacks the evidence base of the 8% patch for postherpetic neuralgia

Clinical Evidence for 8% Patch

Multiple Phase 3 randomized controlled trials demonstrate that a single 60-minute application of the 8% patch provides:

• Pain reduction lasting 8-12 weeks from a single application 1
• 10% more patients reporting significant improvement compared to low-concentration control patches 3
• NNT of 7-9 for patients rating themselves "much or very much improved" at 8 and 12 weeks 3
• Pain relief typically begins after the first 48 hours following initial transient pain increase 2

Application Protocol

The 8% patch requires specialized application conditions 2, 5:

• Pretreat the area with topical lidocaine or oral analgesics (e.g., oxycodone for up to 5 days) to manage the intense initial burning sensation
• Apply to intact, healthy skin only—never to broken or damaged skin 4, 2
• Leave patch in place for exactly 60 minutes 2, 5
• Repeat every 90 days if pain returns or persists 2
• Application typically occurs in specialist pain clinics with monitoring 2

Safety Profile

The 8% patch is well-tolerated with primarily local effects 1, 2:

• Common adverse effects: Application-site burning, erythema, pain, pruritus (transient and self-limiting) 2
• Serious adverse events: No different from placebo (3.5% vs 3.2%) 3
• Systemic absorption: Minimal and clinically insignificant 2
• Important caveat: Skin biopsies show transient epidermal denervation with functional loss of heat pain sensation 1—the long-term safety of repeated applications requires careful evaluation

Critical Distinctions

Do not confuse the 8% patch with over-the-counter low-concentration creams:

• The 8% patch is a prescription medical device requiring controlled application
• OTC creams (0.025-0.075%) 4 lack the evidence base for postherpetic neuralgia and require multiple daily applications with inferior efficacy
• Healthcare staff must take precautions during 8% patch application to avoid unintentional contact 2

Clinical Context

The 8% capsaicin patch offers a unique advantage: sustained pain relief for 2-3 months from a single application 1, avoiding the compliance issues of daily oral medications. This makes it particularly valuable for elderly patients with postherpetic neuralgia who may struggle with polypharmacy and systemic side effects from gabapentinoids, tricyclic antidepressants, or opioids 5.

The relatively high cost and need for specialized application limit its use to patients with severe refractory symptoms 2, but for appropriate candidates, it provides evidence-based relief with minimal systemic effects.